Woolling KR, Ruston JG. Serum neuritis: report of two cases and brief review of the syndrome. Archives of Neurology and Psychiatry 1950;64:568-573.

World Health Organization. Measles Vaccines, Technical Report No. 263. World Health Organization: Geneva; 1963.

WRC-TV. DPT: Vaccine Roulette. Washington DC: WRC-TV, 1982.

Wright PF, Hatch MH, Kasselberg AG, Lowry SP, Wadlington WB, Karzon DT. Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia. Journal of Pediatrics 1977;91:408-412.

Wright PF, Kim-Farley RJ, de Quadros CA, Robertson SE, Scott RM, Ward NA et al. Strategies for the global eradication of poliomyelitis by the year 2000. New England Journal of Medicine 1991;325:1774-1779.

Wutzler P, Sprossig M, Schneider J et al. [A complication after oral protective immunization against poliomyelitis] Komplikation nach oraler Poliomyelitis-Schutzimpfung. Padiatrie und Grenzgebiete 1984;23:289-297.

Wyatt G. Planning an immunization schedule. Practitioner 1992;236:479-480, 482.

Wyatt HV. Poliomyelitis in hypogammaglobulinemics. Journal of Infectious Diseases 1973;128:802-806.

Wyatt HV. Provocation poliomyelitis: neglected clinical observations from 1914 to 1950. Bulletin of the History of Medicine 1981;55:543-557.

Wyatt HV. Did thalidomide promote poliomyelitis following oral poliovirus vaccination in West Berlin in 1960? Perspectives in Biology and Medicine 1983;27:93-106.

Wyatt HV. Injections cripple, injections kill (letter). Journal of the Indian Medical Association 1986;84:193-194.

Wyatt HV. Injections and poliomyelitis: what are the risks of vaccine associated paralysis? Developments in Biological Standardization 1986;65:123-128.

Wyatt HV. Poliovaccination in the Gambia (letter). Lancet 1987;2:43.

Wyatt HV. Incubation of poliomyelitis as calculated from the time of entry into the central nervous system via the peripheral nerve pathways. Reviews of Infectious Diseases 1990;12:547-556.

Wyatt HV. Provocation paralysis (letter). Lancet 1993;341:61-62.

Xu ZY, Margolis HS. Determinants of hepatitis B vaccine efficacy and implications for vaccination strategies. Viral Hepatitis in China: Problems and Control Strategies. Monographs in Virology 1992;19:87-98.

Yamada A, Takeuchi K, Tanabayashi K, Hishiyama M, Takahashi Y, Sugiura A. Differentiation of the mumps vaccine strains from the wild viruses by the nucleotide sequences of the P gene. Vaccine 1990;8:553-557.

Yamauchi T, Wilson C, St. Geme JW. Transmission of live, attenuated mumps virus to the human placenta. New England Journal of Medicine 1974;290:710-712.

Yanagi Y, Cubitt BA, Oldstone MB A. Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell. Virology 1992;187:280-289.

Yap I, Guan R, Chan SH. Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein—a preliminary study on immunogenicity. Vaccine 1992;10:439-442.

Yeoh EK, Chang WK, Ip P, Chan KH, Chan E, Fung C. Efficacy and safety of recombinant hepatitis B vaccine in infants born to HBsAg-positive mothers. Journal of Infection 1986;13(Suppl. A):15-18.

Yogev R, Arditi M, Chadwick EG, Amer MD, Sroka PA. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses. Pediatrics 1990;85(4 Pt 2):690-693.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement